Clinical Trials Directory

Trials / Unknown

UnknownNCT03451136

Cervical Length in Cases of Placenta Previa

Value of Third Trimester Cervical Length Measurement in Predicting Risk and Severity if Antepartum Haemorrhage in Cases of Placenta Previa

Status
Unknown
Phase
Study type
Observational
Enrollment
80 (estimated)
Sponsor
Cairo University · Academic / Other
Sex
Female
Age
25 Years – 40 Years
Healthy volunteers
Accepted

Summary

This study establishes the relationship between cervical length and whether it can be used to predict haemorrhage and preterm delivery in cases of placenta previa.

Detailed description

Some studies have reported an association between ultrasonographic decreased cervical length and the likelihood of complications as antepartum or post-partum haemorrhage requiring an emergency caesarean section (CS) . The safety of trans-vaginal scanning is not in doubt, and the technique now has widespread acceptance. As a consequence, the clinical presentation of placenta previa has changed and most low lying placentas are diagnosed during the second trimester anomaly scan. The objective of this study was to establish if there is a relation between transvaginal ultrasonographic measurement of cervical length in cases of placenta previa and whether it can be used as a predictor for antepartum haemorrhage or not.

Conditions

Timeline

Start date
2018-03-01
Primary completion
2018-07-01
Completion
2018-07-15
First posted
2018-03-01
Last updated
2018-03-01

Source: ClinicalTrials.gov record NCT03451136. Inclusion in this directory is not an endorsement.

Cervical Length in Cases of Placenta Previa (NCT03451136) · Clinical Trials Directory